Welcome to the
European Biotechnology Network!

The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe.

The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.

Read more about our activities here.

Latest Catch

  • © Tiffany Bailey (CC BY 2.0)

    Givaudan bags Induchem

    31.08.2015 In order to boost its active cosmetic ingredients business, the Swiss flavour and fragrance giant Givaudan has acquired Volketswil-based Induchem Holding and all its subsidiaries.

    Just last week, Givaudan announced its rather modest ambitions for the next five years, with a slightly reduced growth goal. In one respect, however, the company is all but modest: Givaudan wants to take over a leading role in the active cosmetic ingredients business. To reach this goal, the flavour and fragrances company has acquired 100% of Induchem Holding AG’s shares, and all its subsidiaries for an undisclosed sum. “Induchem’s business would have represented approximately CHF 25 million (€23m) of incremental sales to Givaudan’s results in 2014 on a proforma basis,” Givaudan said in a press release.

    Induchem, which primarily operates from Volketswil, Switzerland, Toulouse, France and New York, USA, has a product portfolio based on a wide range of active ingredients on offer. With the acquisition, Givaudan will also get access to Induchem’s research expertise in fields such as biocatalysis, metagenomics, and biochemical synthesis. French Induchem subsidiary Libragen is a French biotech that carries out research for the discovery and development of active cosmetic ingredients.

    Gilles Andrier, CEO of Givaudan, said: “Induchem is a second key step, after the acquisition of Soliance, towards our ambition to make Givaudan a significant player in the Active Cosmetic Business. Induchem brings strong complementary capabilities to Givaudan and will greatly contribute in achieving our 2020 ambition to become a key player in this fast growing business.”

    © european-biotechnology-news.com/um

    The Latest Catch is brought to you by European Biotechnology News

Featured Events

Our Corporate Members are


All events


European Biotechnology Network AISBL

Rue de la Science 14b
1040 Brussels, Belgium

Tel: +32 27 33 72 37


Join the European Biotechnology Network!

Individual Membership for natural persons is free, while Corporate Membership, for companies, institutions and research groups start from €500 p.a.

Click here to apply for network membership!

Funding Hub Strategic Partnership

European Biopharmaceutical Enterprises